SUBSCRIBE
SUBSCRIBE
News   Deals

La Jolla Pharmaceutical Company Plans Liquidation

August 4, 2009 | 
1 min read
Bookmark and Share

Xconomy.com -- San Diego’s La Jolla Pharmaceuticals plans to ask shareholders to approve a liquidation plan at a not-yet-scheduled special shareholders meeting, according to a recent SEC filing.
Bankruptcy
MORE ON THIS TOPIC
3d fatty liver disease isolated on pink background. 3d illustration render
MASH
Madrigal Dives Further Into MASH With up to $4.4 siRNA Deal With Chinese Biotech
February 11, 2026
 · 
2 min read
 · 
Tristan Manalac
Creativity and new ideas in business. Art collage.
Mergers & acquisitions
Eli Lilly Enters CAR T Realm With $2.4B Orna Buy, Starting With Autoimmune
February 9, 2026
 · 
2 min read
 · 
Dan Samorodnitsky
Illustration of cardboard box filled with office supplies, a computer keyboard, lamp, and a potted plant
Layoff Tracker
Delayed Notice Reveals 141 More Layoffs From Genentech in 2025
February 9, 2026
 · 
52 min read
 · 
BioSpace Editorial Staff
Insights
Programmable RNA 2.0: Beyond the First mRNA Revolution
February 5, 2026
 · 
1 min read
 · 
Jennifer Smith-Parker